CD19 and lymphoma: When CAR-T cells, possessing the high-affinity anti-CD19 FMC63-based CAR, are co-cultured with CD19-positive lymphoma cells, the CAR-T cells strip CD19 from lymphoma cells and incorporate it into their plasma membrane [42].